HighVista Strategies’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-101,300
| Closed | -$2.23M | – | 164 |
|
|
2024
Q4 | $2.23M | Buy |
101,300
+16,200
| +19% | +$357K | 0.83% | 35 |
|
|
2024
Q3 | $1.53M | Sell |
85,100
-51,400
| -38% | -$926K | 0.53% | 78 |
|
|
2024
Q2 | $2.22M | Buy |
+136,500
| New | +$2.22M | 0.81% | 37 |
|
|
2024
Q1 | – | Sell |
-124,700
| Closed | -$1.3M | – | 153 |
|
|
2023
Q4 | $1.3M | Buy |
124,700
+400
| +0.3% | +$4.18K | 0.47% | 73 |
|
|
2023
Q3 | $1.27M | Buy |
+124,300
| New | +$1.27M | 0.59% | 47 |
|
|
2016
Q4 | – | Sell |
-51,000
| Closed | -$2.35M | – | 211 |
|
|
2016
Q3 | $2.35M | Buy |
51,000
+5,000
| +11% | +$230K | 0.44% | 64 |
|
|
2016
Q2 | $2.31M | Buy |
+46,000
| New | +$2.31M | 0.44% | 59 |
|